Isomorphic Labs President Says AI Will Design All Drugs One Day

Isomorphic Labs president Max Jaderberg projects that artificial intelligence will eventually be used to design every new drug, shifting the timeline from if to when this transition occurs. This perspective signals a long-term goal for the pharmaceutical industry to replace traditional trial-and-error discovery methods with computational modeling. While currently in the early stages of adoption, such a shift could fundamentally accelerate how therapeutic compounds are identified and brought to market.